These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
751 related articles for article (PubMed ID: 23131960)
1. Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Baughman RP; Meyer KC; Nathanson I; Angel L; Bhorade SM; Chan KM; Culver D; Harrod CG; Hayney MS; Highland KB; Limper AH; Patrick H; Strange C; Whelan T Chest; 2012 Nov; 142(5):e1S-e111S. PubMed ID: 23131960 [TBL] [Abstract][Full Text] [Related]
2. Executive summary: monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines. Baughman RP; Meyer KC; Nathanson I; Angel L; Bhorade SM; Chan KM; Culver D; Harrod CG; Hayney MS; Highland KB; Limper AH; Patrick H; Strange C; Whelan T Chest; 2012 Nov; 142(5):1284-1288. PubMed ID: 23131936 [No Abstract] [Full Text] [Related]
3. Monitoring immunosuppressive medications for lung disease and lung transplantation: the time is now. Malesker MA; Morrow LE Chest; 2012 Nov; 142(5):1081-1082. PubMed ID: 23131927 [No Abstract] [Full Text] [Related]
5. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation. Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. Saldanha IJ; Akinyede O; Robinson KA Cochrane Database Syst Rev; 2018 Jun; 6(6):CD009421. PubMed ID: 29921013 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. Saldanha IJ; Akinyede O; Robinson KA Cochrane Database Syst Rev; 2015 Nov; (11):CD009421. PubMed ID: 26559561 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. Saldanha IJ; Akinyede O; McKoy NA; Robinson KA Cochrane Database Syst Rev; 2013 Dec; (12):CD009421. PubMed ID: 24323825 [TBL] [Abstract][Full Text] [Related]
10. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191 [TBL] [Abstract][Full Text] [Related]
11. Current trends in immunosuppression for lung transplantation. Floreth T; Bhorade SM Semin Respir Crit Care Med; 2010 Apr; 31(2):172-8. PubMed ID: 20354930 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppression for lung transplantation. Allan JS Semin Thorac Cardiovasc Surg; 2004; 16(4):333-41. PubMed ID: 15635537 [TBL] [Abstract][Full Text] [Related]
14. Evolving immunosuppressive regimens for lung transplant recipients. Meyer NJ; Bhorade SM Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795 [TBL] [Abstract][Full Text] [Related]
15. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Hong T; Zhang M; Fan J Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009698. PubMed ID: 26457607 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I. Monchaud C; Marquet P Clin Pharmacokinet; 2009; 48(7):419-62. PubMed ID: 19691367 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppression for lung transplantation: evidence to date. Snell GI; Westall GP Drugs; 2007; 67(11):1531-9. PubMed ID: 17661526 [TBL] [Abstract][Full Text] [Related]
18. Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier. Ensor CR; Goehring KC; Iasella CJ; Moore CA; Lendermon EA; McDyer JF; Morrell MR; Sciortino CM; Venkataramanan R; Wiland AM Clin Transplant; 2018 Oct; 32(10):e13363. PubMed ID: 30058177 [TBL] [Abstract][Full Text] [Related]